未知股票 CYTO 深 滬
已收盤
--
0.000
NaN.00%
華盛通- 最 高--
- 今 開--
- 成交量 --
- 最 低 --
- 昨 收 --
- 總市值 0
- 52周最高 --
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 --
- 委 比 0.00%
- 總股本 377.85万
- 歷史最高 --
- 量 比 0
- 振 幅 NaN.00%
- 歷史最低 --
- 每 手 1
- 風險率 1.66%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BRIEF-Cytomed Therapeutics Refutes "Misleading" Claims & Reaffirms Clinical Progress
BRIEF-Cytomed Therapeutics Refutes "Misleading" Claims & Reaffirms Clinical Progress Jan 28 (Reuters) - CytoMed Therapeutics Ltd F98.F : CYTOMED THERAPEUTICS- DOES NOT CLAIM THERAPEUTIC CANDIDATES ARE APPROVED FOR COMMERCIAL USE OR CLINICALLY VALIDATED BEYOND CURRENT DEVELOPMENT STAGE CYTOMED THERAP
01-29 00:04
Cytophage names James Kinley as CFO
Cytophage Technologies (CYTO:CA) said on Tuesday that it has appointed James Kinley, CPA CA, as CFO, succeeding Julius Kalcevich. Kinley brings more than 15 years of experience in the biotech sector,...
01-20 21:49
BRIEF-Bd And Biosero Collaborate To Enable Robotic Integration With Flow Cytometers
Jan 23 (Reuters) - Becton Dickinson and Co BDX.N: BD AND BIOSERO COLLABORATE TO ENABLE ROBOTIC INTEGRATION WITH FLOW CYTOMETERS USED IN DRUG DISCOVERY AND DEVELOPMENT Source text: ID:nBwm2Pg2a Further...
2025-01-23 19:55
BRIEF-Cytokinetics Announces 2025 Corporate Milestones And Vision 2030
Jan 13 (Reuters) - Cytokinetics Inc CYTK.O: CYTOKINETICS ANNOUNCES 2025 CORPORATE MILESTONES AND VISION 2030 CYTOKINETICS INC - PDUFA TARGET ACTION DATE FOR AFICAMTEN SET FOR SEPTEMBER 26, 2025 Source...
2025-01-13 21:49
BRIEF-CytomX Therapeutics Announces 2025 Strategic Pipeline Priorities and Provides Corporate Update
Jan 6 (Reuters) - CytomX Therapeutics Inc CTMX.O: CYTOMX THERAPEUTICS ANNOUNCES 2025 STRATEGIC PIPELINE PRIORITIES AND PROVIDES CORPORATE UPDATE CYTOMX THERAPEUTICS INC - INITIAL PHASE 1A DATA FOR CX-...
2025-01-07 05:21
BRIEF-Cytomed Therapeutics Enters Business & Research Collaboration Agreement With Sunact
Jan 6 (Reuters) - CytoMed Therapeutics Ltd F98.F: CYTOMED THERAPEUTICS LTD - ENTERS BUSINESS & RESEARCH COLLABORATION AGREEMENT WITH SUNACT CYTOMED THERAPEUTICS LTD - BRCA TERM IS FIVE YEARS Source te...
2025-01-06 20:15
BRIEF-Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Cytokinetics Inc CYTK.O: CYTOKINETICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4) Source text: ID:nGNX4hQQkn Further company coverage: CYTK.O
2025-01-04 05:17
“黑科技”站台、医美产品坐镇 美妆企业花样多
转自：中国商报 在今年进博会的舞台上，除了带来“首展首秀”的产品外，美妆企业还在线比拼“黑科技”，他们所在的展馆热闹非凡，有的带来集天气预报、紫外线强度等多项...
2024-11-13 16:34
医药企业共赴进博之约：深耕中国市场发展机遇，追寻行业新质生产力
本报（chinatimes.net.cn）记者杨燕 上海报道 11月10日，第七届进博会在上海“四叶草”会展中心落下帷幕，超过280个观展团，将近3500家企...
2024-11-11 13:59
Altamira Therapeutics Faces Nasdaq Delisting
Altamira Therapeutics (CYTO) has released an update. Altamira Therapeutics Ltd....
2024-10-05 04:28
